Cationic Lipid Compositions for Targeted Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering biologically active agents, such as RNAi agents, face challenges in reaching target cells due to cellular membrane restrictions, requiring high concentrations that can lead to toxic side effects, and existing cationic lipid formulations are not optimized for systemic and local delivery, especially to specific organs like the liver and tumors.
Innovation Solution
Development of a compound of formula (I) and its lipid compositions, which include cationic lipids with specific structural features, forming liposomes or nanoparticles for improved delivery, tailored for systemic and local delivery to cells, tissues, and tumors, with adjustable pKa values for targeted delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If high concentrations of biologically active agents are used to overcome cellular membrane restrictions, then delivery efficacy is improved, but toxic side effects increase
Solution Approach 1:
The patent employs cationic lipid carriers as intermediary vehicles that bind to negatively charged biologically active agents (such as RNAi). These lipid carriers facilitate the transport of the agents across cellular membranes through endocytosis, enabling effective delivery at lower concentrations and thereby reducing toxic side effects while maintaining delivery efficacy.
2Ease of operation
If existing cationic lipid formulations are used for delivery, then cellular uptake is improved, but targeting precision to specific organs and tumors is insufficient
Solution Approach 1:
The patent modifies the properties of cationic lipids to create formulations with specific pKa values and structural characteristics that enable preferential accumulation in target tissues such as tumors and specific organs. This local optimization of lipid properties allows the formulation to maintain general cellular uptake capability while achieving enhanced targeting precision through passive accumulation mechanisms in tissues with specific physiological characteristics.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the delivery of biologically active agents by reducing the need for high concentrations, minimizing side effects, and optimizing targeting to specific organs and tumors, improving the efficacy and safety of therapeutic agents.
Implementation Method 1
The encapsulation of anionic compounds using cationic lipids is essentially quantitative due to electrostatic interaction
Implementation Method 2
it is believed that the cationic lipids interact with the negatively charged cell membranes initiating cellular membrane transport
Data Source
AI summary
This invention provides for a compound of formula (I):or a pharmaceutically acceptable salt thereof, wherein R1-R4, L and X are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.